icon- folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
Boston, Massachusetts
March 4-7, 2018
 Back grey_arrow_rt.gif
 
 
 
PrEP at CROI 2018
 
 
  This is the 1st NATAP summary PrEP report. more coming. There are numerous PrEP updates from many cities below....,
 
CROI: Oral TAF/FTC PrEP Prevents Vaginal SHIV Infection in Monkeys - (03/09/18)
 
CROI: Cabotegravir long-acting protects macaques against repeated penile SHIV exposures (03/12/18)
 
CROI: Low-Dose Oral MK-8591 Protects Monkeys From Rectal SHIV Infection - (03/07/18)
 
CROI: MULTIPLE DAILY DOSES OF MK-8591 AS LOW AS 0.25 MG ARE EXPECTED TO SUPPRESS HIV - (03/05/18)
 
CROI: Protection against repeated vaginal SHIV challenges by bNAb 3BNC117 and 10-1074 - (03/14/18)
 
CROI: Distribution of Active PrEP Prescriptions and the PrEP-to-Need Ratio, US Q2 2017 - (03/07/18)
 
CROI: By Race/ethnicity, Blacks Have Highest Number Needing PrEP in the United States, 2015 (03/28/18)
 
CROI: The PrEP Care Continuum and HIV Racial Disparities among Men Who Have Sex with Men (03/28/18)
 
CROI: Reported PrEP use among HIV-negative partners of US MSM receiving HIV medical care - (04/5/18)
 
CROI: Assessing PrEP Needs Among Heterosexuals and People Who Inject Drugs, Washington, DC - (04/5/18)
 
CROI: Disparities in PrEP Uptake Among Primary Care Patients (03/28/18)
 
CROI: Getting to Zero New Diagnoses in San Francisco: The Potential Role of PrEP (03/28/18)
 
CROI: Geographic Access to PrEP Clinics among US MSM: Documenting PrEP Deserts - (04/4/18)
 
CROI: PREDICTORS OF PrEP ELIGIBILITY AMONG AT-RISK WOMEN IN THE SOUTHERN UNITED STATES - (03/29/18)
 
CROI: HIV BIOMEDICAL PREVENTION AMONG U.S. WOMEN: KNOWLEDGE, BELIEFS, AND PRACTICES - (03/29/18)
 
CROI: Monitoring PrEP Use Among Washington State MSM: Results of an Internet Survey - (04/5/18)
 
CROI: PrEP Implementation and Persistence in a County Health Department in Atlanta, GA - (03/29/18)
 
CROI: HIGH SEROCONVERSION RATES FOLLOWING PrEP DISCONTINUANCE IN A MONTREAL CLINIC - (04/5/18)
 
CROI: DECREASES IN HIV INCIDENCE IN A MONTREAL CLINIC COINCIDE WITH EXPANDING PREP USE - (04/5/18)
 
CROI: PrEP USE HISTORY OF PERSONS NEWLY DIAGNOSED WITH HIV: NEW YORK CITY, 2015-2017 - (04/5/18)
 
CROI: The PREP Cascade at NYC Sexual Health Clinics: Navigation is the Key to Uptake - (03/29/18)
 
CROI: Trends in PrEP Uptake, Adherence, and Discontinuation Among YMSM in Chicago - (04/5/18)
 
CROI: Patterns and Correlates of Participant Retention in the U.S. PrEP Demonstration Project - (04/5/18)
 
CROI: High Discontinuation of Pre-Exposure Prophylaxis Within Six Months of Initiation- Los Amgeles - (04/5/18)
 
CROI: INCREASING PREP UPTAKE, PERSISTENT DISPARITIES, IN AT-RISK PATIENTS IN A BOSTON COMMUNITY HEALTH CENTER - (04/5/18)
 
CROI: Seroconversion on PrEP [4th case]: A Protocol for Untangling Adherence vs. Resistance Failure - (04/4/18)
 
CROI: A Public Health Approach to Viremic Individuals With PrEP-resistant Virus - (04/4/18)
 
CROI: HCV RNA and Antigen Detection for Diagnosis of Acute Hepatitis C Among MSM on PreP..... In the ANRS IPERGAY PrEP trial among high risk MSM - (03/29/18)
 
CROI: HCV incidence in HIV-infected and in PrEP-using MSM - New HCV Rate Similar in HIV+ MSM and HIV- MSM on PrEP in France - (03/27/18)
 
CROI: Low Prevalence of Hepatitis C Virus Among New York City MSM Initiating PrEP and PEP, 2016-2017 at NYC Sexual Health Clinics (03/15/18)
 
CROI: A treatment as prevention trial to eliminate HCV in HIV positive men who have sex with men: The Swiss HCVree Trial - e-health assisted behavioral intervention to reduce risk in HCV re-infection in MSM - (03/15/18)